Background illustration for clinical trials search

Paid Clinical Trials Daytona Beach

Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 884

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain

for

Chronic Pain, Low Back Pain

Location: DeLand FL, Maitland FL, Winter Park FL, Lady Lake FL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07641504

Phase 2, Recruiting

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

for

Osteoarthritis, Knee, Chronic Pain

Location: DeLand FL, Maitland FL, Winter Park FL, Lady Lake FL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 40+

Code: NCT07641517

Phase 2, Recruiting

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

for

Schizophrenia

Location: DeLand FL, Hollywood FL, Miami Lakes FL, Decatur GA,

Sponsor: Leal Therapeutics, Inc

Sex: All

Age: 18 - 55

Code: NCT07734493

Phase 1, Recruiting

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

for

Type 2 Diabetes Mellitus, T2DM

Location: DeLand FL, Orlando FL, The Villages FL, Columbus GA,

Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18 - 70+

Code: NCT07527650

Phase 2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: DeLand FL, Longwood FL, Maitland FL, Orlando FL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for

Uncontrolled Gout

Location: DeLand FL, Winter Park FL, Tampa FL, Largo FL,

Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07388498

Phase 3, Recruiting

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

for

Acute Gout Flare, Gout Attack, Gout Flare, Gouty Arthritis,

Location: DeLand FL, Jacksonville FL, Gainesville FL, Tampa FL,

Sponsor: Olatec Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05658575

Phase 2, Phase 3, Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for

Crohn's Disease

Location: Orange City FL, Orlando FL, Clermont FL, Inverness FL,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

for

Esophageal Stricture

Location: Orange City FL, Orlando FL, Jacksonville FL,

Sponsor: GIE Medical

Sex: All

Age: 22+

Code: NCT05561114

Phase 3, Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

for

Pulmonary Disease, Chronic Obstructive

Location: Orange City FL, The Villages FL, Brandon FL, Tampa FL,

Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06959095

Phase 3, Recruiting

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

for

Tardive Dyskinesia

Location: Orange City FL, Tampa FL, Boca Raton FL,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07365462

Phase 2, Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

for

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder,

Location: Orange City FL, Tampa FL, Port Charlotte FL,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07105111

Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for

Uterine Fibroids, Endometriosis

Location: DeLand FL, Orlando FL, Kissimmee FL, Tampa FL,

Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase 3, Recruiting

A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

for

Attention Deficit Disorder With Hyperactivity (ADHD)

Location: Orange City FL, Maitland FL, Orlando FL, Clermont FL,

Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 65

Code: NCT07755410

Phase 2, Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for

Idiopathic Short Stature

Location: Orange City FL, Jacksonville FL, Miami FL, Columbus GA,

Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase 2, Recruiting

The RESET System Pivotal Clinical Trial (Protocol Revision K)

for

Diabetes type2, Obesity

Location: Orange City FL, Orlando FL, Plant City FL,

Sponsor: Morphic Medical Inc.

Sex: All

Age: 22 - 65

Code: NCT04101669

Recruiting

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

for

Major Depressive Episode (MDE), Major Depressive Disorder (MDD),

Location: Orange City FL, Maitland FL, Orlando FL,

Sponsor: Tonix Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07621237

Phase 2, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for

Non-small Cell Lung Cancer

Location: Orange City FL, Ocala FL, Jacksonville FL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for

Non-Small Cell Lung Cancer

Location: Orange City FL, Orlando FL, Clermont FL, Gainesville FL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for

Non Small Cell Lung Cancer

Location: Orange City FL, Jacksonville FL, Savannah GA,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

Paid Clinical Trials Daytona Beach

Filter results

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Interested in new trials?

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

The RESET System Pivotal Clinical Trial (Protocol Revision K)

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)